dr. rugo discusses how stomatitis impacts the efficacy of everolimus
Published 10 years ago • 308 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:52
dr. rugo on swish trial for hr-positive breast cancer
-
5:01
managing mouth sores from everolimus in breast cancer
-
1:57
dr. rugo on results of oral paclitaxel with encequidar in metastatic breast cancer
-
1:16
archana ajmera on stomatitis prevention during everolimus/exemestane treatment
-
4:29
managing the toxicity of everolimus in breast cancer
-
1:55
dr. rugo on pathway blockade in breast cancer
-
1:50
dr. slomovitz discusses a study of everolimus/letrozole or hormonal therapy in endometrial cancer
-
7:37
next steps for everolimus in er-positive metastatic breast cancer
-
10:09
hope rugo, md: advances and challenges in the treatment of metastatic breast cancer
-
8:33
bolero-2 trial: everolimus in metastatic breast cancer
-
9:15
sequencing and role of everolimus in hr-positive breast cancer
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
3:43
second-line everolimus in metastatic breast cancer
-
1:24
dr. perez discusses the bolero-2 everolimus trial
-
2:56
everolimus in er-positive breast cancer
-
0:40
archana ajmera discusses the challenges of managing stomatitis
-
3:37
long-term use of everolimus is safe and efficacious in patients with tuberous sclerosis complex
-
2:08
dr. jose baselga compares the mtor inhibitors temsirolimus and everolimus
-
3:52
dry mouth: causes, issues, and treatments